Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 18-Jan-24 8:22 PM View:  | Regulus Therapeutics Inc. (RGLS) | 18-Jan-24 | Private Sale (Planned) | 14,580 | $1.19 | $17,358.90 | (20%) 71.69K to 57.11K | |
| 17-Jan-24 5:16 PM View: | Regulus Therapeutics Inc. (RGLS) | 12-Jan-24 | Grant | 30,000 | -- | -- | 72% 41.69K to 71.69K | |
| 23-May-23 5:18 PM View: | Aurinia Pharmaceuticals Inc. (AUPH) | 19-May-23 | Option Sale | 272 | $10.58 | $2,877.76 | (2%) 12.23K to 11.96K | |
| 23-May-23 5:18 PM View: | Aurinia Pharmaceuticals Inc. (AUPH) | 18-May-23 | Option Exercise | 8,733 | -- | -- | 250% 3.5K to 12.23K | |
| 26-Jan-22 4:13 PM View: | Regulus Therapeutics Inc. (RGLS) | 26-Jan-22 | Private Purchase | 100,000 | $0.22 | $21,520.00 | 32% 317.01K to 417.01K | |
| 04-Jan-22 4:17 PM View: | Aurinia Pharmaceuticals Inc. (AUPH) | 03-Jan-22 | Option Exercise | 40,000 | $5.08 | $203,200.00 | 1143% 3.5K to 43.5K | |
| 04-Jan-22 4:17 PM View: | Aurinia Pharmaceuticals Inc. (AUPH) | 03-Jan-22 | Market Option Sale (Planned) | 40,000 | $22.59 | $903,650.00 | (92%) 43.5K to 3.5K | |
| 14-Jun-21 8:31 PM View: | Zosano Pharma Corp (ZSAN) | 10-Jun-21 | Grant | 15,000 | -- | -- | 200% 7.5K to 22.5K | |
| 17-May-21 7:13 PM View: | Regulus Therapeutics Inc. (RGLS) | 17-May-21 | Market Sale (Planned) | 4,186 | $0.89 | $3,725.54 | (1%) 320.48K to 316.29K | (2%) |
| 16-Apr-21 10:00 PM View: | Regulus Therapeutics Inc. (RGLS) | 14-Apr-21 | Conversion | 75,850 | -- | -- | 31% 244.63K to 320.48K | |
| 17-Feb-21 5:23 PM View: | Regulus Therapeutics Inc. (RGLS) | 16-Feb-21 | Market Sale (Planned) | 4,144 | $1.72 | $7,127.68 | (< 1%) 489.9K to 485.76K | (13%) |
| 07-Dec-20 4:22 PM View: | Regulus Therapeutics Inc. (RGLS) | 04-Dec-20 | Grant | 39,680 | $0.63 | $25,002.40 | 21% 185.99K to 225.67K | |
| 18-Nov-20 4:09 PM View: | Regulus Therapeutics Inc. (RGLS) | 16-Nov-20 | Market Sale (Planned) | 6,094 | $0.52 | $3,175.58 | (3%) 222.09K to 215.99K | (179%) |
| 17-Aug-20 8:22 PM View: | Regulus Therapeutics Inc. (RGLS) | 14-Aug-20 | Market Sale (Planned) | 4,245 | $0.60 | $2,567.80 | (2%) 226.33K to 222.09K | (154%) |
| 30-Jun-20 10:00 PM View: | Zosano Pharma Corp (ZSAN) | 25-Jun-20 | Grant | 7,500 | -- | -- | 100% 0 to 7.5K | |
| 18-May-20 4:28 PM View: | Regulus Therapeutics Inc. (RGLS) | 15-May-20 | Market Sale (Planned) | 4,426 | $0.63 | $2,773.77 | (2%) 230.76K to 226.33K | (147%) |
| 19-Feb-20 6:09 PM View: | Regulus Therapeutics Inc. (RGLS) | 18-Feb-20 | Market Sale (Planned) | 4,324 | $0.83 | $3,590.65 | (2%) 235.08K to 230.76K | (92%) |
| 03-Jan-20 4:07 PM View: | Regulus Therapeutics Inc. (RGLS) | 02-Jan-20 | Market Sale (Planned) | 8,345 | $0.97 | $8,067.11 | (3%) 243.43K to 235.08K | (65%) |
| 15-Nov-19 5:36 PM View: | Regulus Therapeutics Inc. (RGLS) | 14-Nov-19 | Market Sale (Planned) | 5,838 | $0.64 | $3,736.32 | (2%) 249.27K to 243.43K | (146%) |
| 02-Oct-19 6:17 PM View: | Regulus Therapeutics Inc. (RGLS) | 01-Oct-19 | Market Sale (Planned) | 8,743 | $0.68 | $5,968.85 | (3%) 258.01K to 249.27K | (128%) |
| 16-Aug-19 4:17 PM View: | Regulus Therapeutics Inc. (RGLS) | 15-Aug-19 | Market Sale (Planned) | 4,375 | $0.55 | $2,408.88 | (2%) 262.38K to 258.01K | (184%) |
| 02-Jul-19 5:42 PM View: | Regulus Therapeutics Inc. (RGLS) | 01-Jul-19 | Market Sale (Planned) | 5,783 | $1.31 | $7,584.40 | (2%) 268.17K to 262.38K | (18%) |
| 16-May-19 5:25 PM View: | Regulus Therapeutics Inc. (RGLS) | 16-May-19 | Market Sale (Planned) | 39,352 | $1.22 | $47,966.20 | (13%) 307.52K to 268.17K | (28%) |
| 16-May-19 5:25 PM View: | Regulus Therapeutics Inc. (RGLS) | 14-May-19 | Grant | 188,385 | -- | -- | 158% 119.13K to 307.52K | |
| 08-May-19 5:15 PM View: | Regulus Therapeutics Inc. (RGLS) | 07-May-19 | Private Purchase | 33,194 | $1.08 | $35,849.50 | 106% 31.35K to 64.54K | |
| 03-Apr-19 4:31 PM View: | Regulus Therapeutics Inc. (RGLS) | 01-Apr-19 | Market Sale (Planned) | 5,842 | $0.98 | $5,731.00 | (16%) 37.19K to 31.35K | (58%) |
| 06-Feb-19 4:51 PM View: | Regulus Therapeutics Inc. (RGLS) | 05-Feb-19 | Grant | 65,000 | $0.95 | $61,750.00 | 339% 19.15K to 84.15K | 66% |
| 25-Jul-17 6:08 PM View: | Regulus Therapeutics Inc. (RGLS) | 25-Jul-17 | Private Purchase | 219,780 | $0.91 | $200,000.00 | 1021% 21.52K to 241.3K | |
| 07-Mar-16 5:20 PM View: | Regulus Therapeutics Inc. (RGLS) | 03-Mar-16 | Market Purchase | 10,000 | $7.19 | $71,900.00 | 100% 0 to 10.0K | (98%) |
| 15-Sep-14 3:11 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 15-Sep-14 | Market Purchase | 5,000 | $4.69 | $23,450.00 | 62% 8.03K to 13.03K | (93%) |
| 11-Feb-14 7:33 AM View: | Orexigen Therapeutics, Inc. (OREXQ) | 29-Nov-13 | Grant | 3,980 | $5.34 | $21,253.20 | 100% 0 to 3.98K | |
| 02-Aug-13 7:34 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 31-Jul-13 | Option Exercise | 12,000 | $1.66 | $19,920.00 | 100% 0 to 12.0K | |
| 02-Aug-13 7:34 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 31-Jul-13 | Market Option Sale (Planned) | 12,000 | $7.80 | $93,600.00 | (100%) 12.0K to 0 | 96% |
| 29-Jul-13 7:49 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 26-Jul-13 | Option Exercise | 10,000 | $1.66 | $16,600.00 | 100% 0 to 10.0K | |
| 29-Jul-13 7:49 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 26-Jul-13 | Market Option Sale (Planned) | 10,000 | $7.40 | $74,000.00 | (100%) 10.0K to 0 | 96% |
| 30-May-13 5:38 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 28-May-13 | Option Exercise | 28,000 | $1.66 | $46,480.00 | 100% 0 to 28.0K | |
| 30-May-13 5:38 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 28-May-13 | Market Option Sale (Planned) | 28,000 | $7.00 | $196,000.00 | (100%) 28.0K to 0 | 95% |
| 13-Jul-12 8:13 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 13-Jul-12 | Option Exercise | 30,000 | $1.66 | $49,800.00 | 100% 0 to 30.0K | |
| 13-Jul-12 8:13 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 13-Jul-12 | Market Option Sale (Planned) | 30,000 | $6.77 | $203,000.00 | (100%) 30.0K to 0 | 95% |
| 29-Jun-12 6:58 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 29-Jun-12 | Option Exercise | 12,000 | $1.66 | $19,920.00 | 100% 0 to 12.0K | |
| 29-Jun-12 6:58 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 29-Jun-12 | Market Option Sale (Planned) | 12,000 | $6.30 | $75,600.00 | (100%) 12.0K to 0 | 95% |
| 29-Jun-12 6:58 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 28-Jun-12 | Option Exercise | 26,000 | $1.66 | $43,160.00 | 100% 0 to 26.0K | |
| 29-Jun-12 6:58 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 28-Jun-12 | Market Option Sale (Planned) | 26,000 | $5.90 | $153,400.00 | (100%) 26.0K to 0 | 95% |
| 29-Jun-12 6:58 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 27-Jun-12 | Option Exercise | 70,000 | $1.66 | $116,200.00 | 100% 0 to 70.0K | |
| 29-Jun-12 6:58 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 27-Jun-12 | Market Option Sale (Planned) | 70,000 | $5.26 | $368,000.00 | (100%) 70.0K to 0 | 94% |